Journal Watch

  • Regional Variation in PD Infection Prevention

    A PDOPPS analysis of surveys from medical directors caring for more than 11,000 patients from 170 clinics in seven countries (Australia, New Zealand, Canada, Thailand, Japan, the UK, and the US) found variation from 63% to 100% in use of antibiotic prophylaxis for PD exit sites, with mupirocin used most often.

    Read the abstract » | (added 2018-08-13)

    Tags: Peritoneal Dialysis related Infections, Peritoneal Dialysis, Infections, Peritoneal Dialysis Outcomes

  • Color of Used PD Dialysate Gives Diagnostic Clues

    A review article proposes a differential diagnosis of various conditions based on a change in the color of PD effluent from clear to red, orange, cloudy, milky white, green, yellow, purple or black.

    Read the abstract » | (added 2018-08-13)

    Tags: Bloody Effluent, Chyloperitoneum, Peritoneal Dialysis, Peritonitis, Rhabdomyolysis

  • New Model Could Help Screen PD Patients for CeVD Risk

    A new risk score could predict how likely new PD patients are to develop cerebrovascular disease down the road. The strongest predictors of CeVD were blood pressure, total cholesterol, and serum phosphate and sodium levels.

    Read the abstract » | (added 2018-08-13)

    Tags: Cerebrovascular Diseases, Mortality, Peritoneal Dialysis, Risk Prediction

  • Home HD After PD Failure May Lead to More Transplants, Lower Mortality

    Since PD failure can lead to hospitalization and death in those who switch to standard in-center HD (ICHD), would outcomes improve with home HD? A new analysis found 521 patients in the USRDS data who made the change. Compared to matched ICHD patients, the chance of transplant was nearly double (21% vs. 10.6%), while survival of home HD patients was 89.1% at 1 year and 80.5% at 2 years.

    Read the abstract » | (added 2018-08-13)

    Tags: PD Technique Failure, ICHD, Transplant, Home HD, Lower Mortality

  • Nephrologists’ attitudes toward intensified HD

    Among German nephrologists, 44% believe there is not enough evidence in favor of intensified HD, whether or not they offer it. Respondents cited a need for more funding and more staff to support the therapy. Among the 44% who did offer the option, most reserved it for patients who were not receiving adequate treatment with conventional HD, and just 19% offered it routinely. Read the abstract.

    Read the abstract » | (added 2018-07-13)

    Tags: Intensified HD

  • Vitamin D and Cinacalcet linked to PD survival—but not residual kidney function

    In a retrospective look at 581 PD patients, use of Vitamin D and cinacalcet (which have antiinflammatory properties) were linked with 56% and 54% lower risks of death, respectively. But, neither drug slowed the loss of residual function. Read the abstract.

    Read the abstract » | (added 2018-07-13)

    Tags: Vitamin D, Cinacalcet, Risidual Function

  • Vascular access for high-risk PD patients

    Which PD patients are at risk for technique failure and should proactively have a vascular access placed for HD? A case-control study compared 72 patients who were transferred from PD to HD to 111 controls who stayed on PD, received a transplant, recovered kidney function, or passed away. Low adequacy or serum albumin, hospitalizations, and peritonitis were predictors of a transfer to HD. Read the abstract.

    Read the abstract » | (added 2018-07-13)

    Tags: PD, Technique, Vascular Access, HD

  • Does RRF affect quality of life in CAPD?

    The SF-36 was given to 120 adult patients on CAPD for at least 3 months, divided into a group with and without residual renal function. There were no correlations between RRF and total SF-36 scores. However, SF-36 scores did correlate with measures of inflammation, fluid overload, and malnutrition. Read the abstract.

    Read the abstract » | (added 2018-07-13)

    Tags: SF 36, CAPD, RRF

  • Lower B2M levels linked with WORSE survival on PD

    Unlike HD, a new study of 725 incident PD patients divided into three beta-2 microglobulin tertiles found that the lowest third of B2m levels was associated with a higher risk of death. The increased risk was especially seen in females; older patients; and those with comorbidities, low BMI, low serum albumin, and less residual kidney function. Read the abstract.

    Read the abstract » | (added 2018-07-13)

    Tags: PD, B2m, Morbidity Rate

  • PKD and PD – a Metaanalysis

    Among 9 studies totaling 7,197 patients—of whom 882 had polycystic kidney disease—survival was better among the PKD patients. There were no differences in peritonitis or technique survival between those who did and did not have PKD, though those with PKD did have a higher risk of hernias.

    Read the abstract » | (added 2018-06-12)

    Tags: PKD, PD, Metaanalysis, Polycystic Kidney Disease